SYBLEU IncOTC Pink - Current Information:SYBE
- LAST PRICE0.0590
- TODAY'S CHANGE (%)-0.0201 (-25.3797%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0700 / 0.0790
- Day Range
- 52 Week Range
- Volume20,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SYBE |
|---|---|---|
| 01:35 ET | 14000 | 0.0745 |
| 01:42 ET | 1000 | 0.0743 |
| 02:36 ET | 5000 | 0.05895 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
SYBLEU Inc | 5.9M | -2.0x | --- |
Sentient Brands Holdings Inc | 6.4M | -14.0x | --- |
Resonate Blends Inc | 3.4M | -2.0x | --- |
CanaQuest Medical Corp | 3.0M | -2.7x | --- |
Bioquest Corp | 1.5M | -2.7x | --- |
Rapid Therapeutic Science Laboratories Inc | 104.6K | 0.9x | --- |
Company Information
SYBLEU Inc. is engaged in the acquisition, licensing and development of medical and veterinary applications. The Company is focused on developing therapies for human and animal health, medical devices, and clinical diagnostics. The Company is also developing drugs for treating cancer in companion animals and examining the role of artificial intelligence and machine learning in clinical diagnostics. It is also involved in the development of disposable medical devices. It has completed Phase I and or Phase II clinical trials after which the Company would either attempt to sell or license those developed applications or, alternatively, advance the application further to Phase III clinical trials.
Contact Information
- Headquarters
- 1034 Throggs Neck ExpresswayBRONX, NY, United States 10465
- Phone
- 718-795-7790
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Jeremy Davey
- President, Director
- Laman Milner
- Company Secretary, Director
- John Clark
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.9M |
|---|---|
Revenue (TTM) | $11.7K |
Shares Outstanding | 99.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.03 |
Book Value | $-0.03 |
P/E Ratio | -2.0x |
Price/Sales (TTM) | 500.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -2,452.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
